Capstone Investment Advisors, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Capstone Investment Advisors, LLC
- $35.4 Billion
- Q1 2025
A detailed history of Capstone Investment Advisors, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 16,150 shares of AMLX stock, worth $76,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,150Holding current value
$76,228% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
72.6MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$37.2 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$28.1 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$26.9 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$19.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$14.5 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $276M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...